FY2013 Defense Authorization and Appropriations, and More from CRS
New and updated reports from the Congressional Research Service that have not been made readily available to the public include the following.
Defense: FY2013 Authorization and Appropriations, July 13, 2012
The Unified Command Plan and Combatant Commands: Background and Issues for Congress, July 17, 2012
LIBOR: Frequently Asked Questions, July 16, 2012
The 2001 and 2003 Bush Tax Cuts and Deficit Reduction, July 16, 2012
Guatemala: Political, Security, and Socio-Economic Conditions and U.S. Relations, June 26, 2012
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.